An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques

Science Translational Medicine

Volumn 4, Issue 150, 2012, Pages

  Singer, Rachel ^a   Mawson, Paul ^a   Derby, Nina ^a   Rodriguez, Aixa ^a   Kizima, Larisa ^a   Menon, Radhika ^a   Goldman, Daniel ^a   Kenney, Jessica ^a   Aravantinou, Meropi ^a   Seidor, Samantha ^a   Gettie, Agegnehu ^b   Blanchard, James ^c   Piatak, Michael ^d   Lifson, Jeffrey D ^d   Fernández Romero, José A ^a   Robbiani, Melissa ^a   Zydowsky, Thomas M ^a  

^a POPULATION COUNCIL   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE VINYL ACETATE COPOLYMER; MIV 150; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PLACEBO; RNA DIRECTED DNA POLYMERASE; SILICONE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG STRUCTURE; DRUG TISSUE LEVEL; FEMALE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MACACA; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA DISCHARGE; VAGINA RING; VIRUS TRANSMISSION;

EID: 84865986541     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003936     Document Type: Article

References (47)

1. Q. Abdool Karim, S. S. Abdool Karim, J. A. Frohlich, A. C. Grobler, C. Baxter, L. E. Mansoor, A. B. Kharsany, S. Sibeko, K. P. Mlisana, Z. Omar, T. N. Gengiah, S. Maarschalk, N. Arulappan, M. Mlotshwa, L. Morris, D. Taylor; CAPRISA 004 Trial Group, Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329, 1168-1174 (2010).
2. S. Skoler-Karpoff, G. Ramjee, K. Ahmed, L. Altini, M. G. Plagianos, B. Friedland, S. Govender, A. De Kock, N. Cassim, T. Palanee, G. Dozier, R. Maguire, P. Lahteenmaki, Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial. Lancet 372, 1977-1987 (2008).
3. The ART of preventing HIV. Nat. Med. 17, 46-47 (2011).
4. J. Cohen, AIDS research. Complexity surrounds HIV prevention advances. Science 333, 393 (2011).
5. J. Kerns, P. Darney, Vaginal ring contraception. Contraception 83, 107-115 (2011).
6. R. K. Malcolm, K. L. Edwards, P. Kiser, J. Romano, T. J. Smith, Advances in microbicide vaginal rings. Antiviral Res. 88 (Suppl. 1), S30-S39 (2010).
7. R. Barentsen, P. H. van de Weijer, J. H. Schram, Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur. J. Obstet. Gynecol. Reprod. Biol. 71, 73-80 (1997).
8. A. Penman-Aguilar, T. Swezey, A. N. Turner, A. J. Bell, F. N. Ramiandrisoa, J. Legardy-Williams, B. Randrianasolo, K. Van Damme, J. Dulyx, F. Behets, D. J. Jamieson, Promoting continuous use as a strategy for achieving adherence in a trial of the diaphragm with candidate microbicide. AIDS Educ. Prev. 21, 512-525 (2009).
9. K. Malcolm, D. Woolfson, J. Russell, P. Tallon, L. McAuley, D. Craig, Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings. J. Control. Release 90, 217-225 (2003).
10. T. J. Johnson, K. M. Gupta, J. Fabian, T. H. Albright, P. F. Kiser, Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur. J. Pharm. Sci. 39, 203-212 (2010).
11. J. A. Moss, A.M.Malone, T. J. Smith, S. Kennedy, E. Kopin, C. Nguyen, J. Gilman, I. Butkyavichene, K. L. Vincent, M. Motamedi, D. R. Friend, M. R. Clark, M. M. Baum, Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob. Agents Chemother. 56, 875-882 (2012).
12. R. K. Malcolm, R. S. Veazey, L. Geer, D. Lowry, S. M. Fetherston, D. J. Murphy, P. Boyd, I. Major, R. J. Shattock, P. J. Klasse, L. A. Doyle, K. K. Rasmussen, L. Goldman, T. J. Ketas, J. P. Moore, Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques. Antimicrob. Agents Chemother. 56, 2251-2258 (2012).
13. P. F. Kiser, T. J. Johnson, J. T. Clark, State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev. 14, 62-77 (2012).
14. J. Kenney, M. Aravantinou, R. Singer, M. Hsu, A. Rodriguez, L. Kizima, C. J. Abraham, R. Menon, S. Seidor, A. Chudolij, A. Gettie, J. Blanchard, J. D. Lifson, M. Piatak Jr., J. A. Fernández-Romero, T. M. Zydowsky, M. Robbiani, An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. PLoS One 6, e15835 (2011).
15. L. Tang, S. U. Khan, N. A. Muhammad, Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity. Pharm. Dev. Technol. l6, 531-540 (2001).
16. A. Rodriguez, J. Fernandez-Romero, personal communication.
17. J. A. van Laarhoven, M. A. Kruft, H. Vromans, In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring. Int. J. Pharm. 232, 163-173 (2002).
18. S. Hild-Petito, R. S. Veazey, J. M. Larner, J. R. Reel, R. P. Blye, Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Res. Hum. Retroviruses 14 (Suppl. 1), S125-S130 (1998).
19. S. G. Turville,M. Aravantinou, T. Miller, J. Kenney, A. Teitelbaum, L. Hu, A. Chudolij, T.M. Zydowsky, M. Piatak Jr., J. W. Bess Jr., J. D. Lifson, J. Blanchard, A. Gettie, M. Robbiani, Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. PLoS One 3, e3162 (2008).
20. T. J. Johnson, P. Srinivasan, T. H. Albright, K. Watson-Buckheit, L. Rabe, A. Martin, C. P. Pau, R. M. Hendry, R. Otten, J. McNicholl, R. Buckheit Jr., J. Smith, P. F. Kiser, Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings. Antimicrob. Agents Chemother. 56, 1291-1299 (2012).
21. M. R. Clark, T. J. Johnson, R. T. McCabe, J. T. Clark, A. Tuitupou, H. Elgendy, D. R. Friend, P. F. Kiser, A hot-melt extruded intravaginal ring for the sustained delivery of the anti-retroviral microbicide UC781. J. Pharm. Sci. 101, 576-587 (2012).
22. A. Nel, S. Smythe, K. Young, K. Malcolm, C. McCoy, Z. Rosenberg, J. Romano, Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women. J. Acquir. Immune Defic. Syndr. 51, 416-423 (2009).
23. J. A. Fernández-Romero, M. Thorn, S. G. Turville, K. Titchen, K. Sudol, J. Li, T. Miller, M. Robbiani, R. A. Maguire, R. W. Buckheit Jr., T. L. Hartman, D. M. Phillips, Carrageenan/MIV-150 (PC-815), a combination microbicide. Sex. Transm. Dis. 34, 9-14 (2007).
24. Y. W. Chien, H. J. Lambert, Controlled drug release from polymeric delivery devices. II. Differentiation between partition-controlled and matrix-controlled drug release mechanisms. J. Pharm. Sci. 63, 515-519 (1974).
25. D. L. Patton, G. G. Kidder, Y. C. Sweeney, L. K. Rabe, S. L. Hillier, Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am. J. Obstet. Gynecol. 180, 1080-1087 (1999).
26. N. Promadej-Lanier, P. Srinivasan, K. Curtis, D. R. Adams, C. Kim, W. Luo, H. Jia, S. Subbarao, R. A. Otten, S. Butera, Systemic and mucosal immunological responses during repeated mucosal SHIV162P3 challenges prior to and following infection in pigtailed macaques. Virology 375, 492-503 (2008).
27. R. A. Otten, D. R. Adams, C. N. Kim, E. Jackson, J. K. Pullium, K. Lee, L. A. Grohskopf, M. Monsour, S. Butera, T. M. Folks, Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates. J. Infect. Dis. 191, 164-173 (2005).
28. C. Dobard, S. Sharma, A. Martin, C. P. Pau, A. Holder, Z. Kuklenyik, J. Lipscomb, D. L. Hanson, J. Smith, F. J. Novembre, J. G. García-Lerma, W. Heneine, Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. J. Virol. 86, 718-725 (2012).
29. U. M. Parikh, C. Dobard, S. Sharma, M. E. Cong, H. Jia, A. Martin, C. P. Pau, D. L. Hanson, P. Guenthner, J. Smith, E. Kersh, J. G. Garcia-Lerma, F. J. Novembre, R. Otten, T. Folks, W. Heneine, Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J. Virol. 83, 10358-10365 (2009).
30. C. Cheng-Mayer, Y. Huang, A. Gettie, L. Tsai, W. Ren, M. Shakirzyanova, S. T. Sina, N. Trunova, J. Blanchard, L. M. Jenkins, Y. Lo, M. L. Schito, E. Appella, Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide. AIDS 25, 1833-1841 (2011).
31. S. A. Vishwanathan, P. C. Guenthner, C. Y. Lin, C. Dobard, S. Sharma, D. R. Adams, R. A. Otten, W. Heneine, R. M. Hendry, J. M. McNicholl, E. N. Kersh, High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J. Acquir. Immune Defic. Syndr. 57, 261-264 (2011).
32. D. H. Owen, D. F. Katz, A vaginal fluid simulant. Contraception 59, 91-95 (1999).
33. A. R. Geonnotti, D. F. Katz, Compartmental transport model of microbicide delivery by an intravaginal ring. J. Pharm. Sci. 99, 3514-3521 (2010).
34. J. Blanchard, personal communication.
35. S. S. Karim, A. D. Kashuba, L. Werner, Q. A. Karim, Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: Implications for HIV prevention in women. Lancet 378, 279-281 (2011).
36. J. Romano, B. Variano, P. Coplan, J. Van Roey, K. Douville, Z. Rosenberg, M. Temmerman, H. Verstraelen, L. Van Bortel, S. Weyers, M. Mitchnick, Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res. Hum. Retroviruses 25, 483-488 (2009).
37. R. K. Malcolm, A. D. Woolfson, C. F. Toner, R. J. Morrow, S. D. McCullagh, Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. J. Antimicrob. Chemother. 56, 954-956 (2005).
38. J. A. Fernández-Romero, C. J. Abraham, A. Rodriguez, L. Kizima, N. Jean-Pierre, R. Menon, O. Begay, S. Seidor, B. E. Ford, P. I. Gil, J. Peters, D. Katz, M. Robbiani, T. M. Zydowsky, Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob. Agents Chemother. 56, 358-368 (2012).
39. O. Begay, N. Jean-Pierre, C. J. Abraham, A. Chudolij, S. Seidor, A. Rodriguez, B. E. Ford, M. Henderson, D. Katz, T. Zydowsky, M. Robbiani, J. A. Fernández-Romero, Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res. Hum. Retroviruses 27, 1019-1024 (2011).
40. Animal Welfare Act and Regulation of 2001, Code of Federal Regulations, Chapter 1, Sub-chapter A: Animals and Animal Products (U.S. Department of Agriculture, Beltsville, MD, 2001).
41. Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Guide for the Care and Use of Laboratory Animals (U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD, 1985), pp. 1-83.
42. R. Singer, N. Derby, A. Rodriguez, L. Kizima, J. Kenney, M. Aravantinou, A. Chudolij, A. Gettie, J. Blanchard, J. D. Lifson, M. Piatak Jr., J. A. Fernández-Romero, T. M. Zydowsky, M. Robbiani, The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques. J. Virol. 85, 5504-5512 (2011).
43. I. Frank, M. Piatak Jr., H. Stoessel, N. Romani, D. Bonnyay, J. D. Lifson, M. Pope, Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): Differential intracellular fate of virions in mature and immature DCs. J. Virol. 76, 2936-2951 (2002).
44. F. Crostarosa, M. Aravantinou, O. J. Akpogheneta, E. Jasny, A. Shaw, J. Kenney, M. Piatak, J. D. Lifson, A. Teitelbaum, L. Hu, A. Chudolij, T. M. Zydowsky, J. Blanchard, A. Gettie, M. Robbiani, A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy. PLoS One 4, e8060 (2009).
45. N. Kumar, A. K. Didolkar, A. Ladd, R. Thau, C. Monder, C. W. Bardin, K. Sundaram, Radio-immunoassay of 7 alpha-methyl-19-nortestosterone and investigation of its pharmacokinetics in animals. J. Steroid Biochem. Mol. Biol. 37, 587-591 (1990).
46. S. M. Smith, B. Holland, C. Russo, P. J. Dailey, P. A. Marx, R. I. Connor, Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: Predictive value for disease progression. AIDS Res. Hum. Retroviruses 15, 1691-1701 (1999).
47. A. Agresti, A survey of exact inference for contingency tables. Statist. Sci. 7, 131-153 (1992).